Why One Analyst Is Souring on Oracle Ahead of Earnings

Photo of Chris Lange
By Chris Lange Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Why One Analyst Is Souring on Oracle Ahead of Earnings

© maybefalse / Getty Images

Oracle Corp. (NYSE: ORCL) is set to release its most recent quarterly results after the markets close Wednesday. The consensus estimates are calling for $1.07 in earnings per share (EPS) and $10.95 billion in revenue. The fiscal fourth quarter from last year had $0.99 in EPS and $11.26 billion in revenue.

Ahead of the report one key analyst soured on Oracle—specifically Macquarie’s Sarah Hindlian. Overall Oracle was downgraded to a Neutral rating from Outperform, citing concerns about the firm’s outlook and likely winding down its aggressive buyback program. The price target was also cut to $55 from $56.

Hindlian writes in a research note that her checks find Oracle had a “struggle” in the final weeks of the quarter. She detailed that partners rushed to discount orders up until the final days, yet Macquarie believes Oracle has a very easy bar and comp. Although there are several leading partners seeing softening of the pipeline, it’s Macquarie’s belief that there is a step function lower in demand for Oracle and it is appropriate to re-evaluate.

She went on to say:

We are downgrading shares of Oracle to Neutral following partner commentary suggesting significantly softening Oracle practices. We think Oracle has sig. value it can unlock especially in Cloud ERP, and Autonomous DB, and note easy comps for the fiscal fourth quarter. However, we see risks to guidance and shares as the $10 billion buyback may wind down in the next 1-2 quarters.

[nativounit]

A few other analysts weighed in on Oracle as well:

  • JPMorgan has a Neutral rating with a $53 price target.
  • UBS Group has a Neutral rating with a $54 price target.
  • Morgan Stanley has an Equal Weight rating with a $59 price target.
  • Credit Suisse has a Buy rating with a $60 price target

Overall Oracle has outperformed the broad markets with the stock up nearly 18% year to date. In the past 52 weeks, the stock is up closer to 16%.

Shares of Oracle were last seen at $53.24, with a 52-week range of $42.40 to $55.53. The consensus analyst price target is $53.41.

[recirclink id=554914]

[wallst_email_signup]

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Our $500K AI Portfolio

See us invest in our favorite AI stock ideas for free

Our Investment Portfolio

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618